What is the current Price Target for the Rocket Pharmaceuticals, Inc. stock?

The average Rocket Pharmaceuticals, Inc. target price is $10.20. This is 298.44% higher than the current stock price. The highest price target is 515.23%, the lowest is 18.36%. 13 Analysts have issued a price target Rocket Pharmaceuticals, Inc. 2027 .

How high will the Rocket Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Rocket Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Rocket Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Rocket Pharmaceuticals, Inc. stock today?

The performance of Rocket Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Rocket Pharmaceuticals, Inc. stock fall?

The decline in Rocket Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Rocket Pharmaceuticals, Inc. Forecast, price target & analysts

$2.56

1.16%

Nasdaq, Oct 02, 04:00 pm EDT. Closed.

ISIN

US77313F1066

Symbol

RCKT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Rocket Pharmaceuticals, Inc. Target price 2026 - Analyst rating & recommendation

Rocket Pharmaceuticals, Inc. Classifications & Recommendation

Buy

55%

Hold

35%

Sell

10%

Rocket Pharmaceuticals, Inc. Price Target

Target Price	$10.20
Price	$2.56
Potential	298.44% register free of charge
Number of Estimates	13

	13 Analysts have issued a price target Rocket Pharmaceuticals, Inc. 2027 . The average Rocket Pharmaceuticals, Inc. target price is $10.20. This is 298.44% register free of charge higher than the current stock price. The highest price target is $15.75 515.23% register free of charge , the lowest is $3.03 18.36% register free of charge .
	A rating was issued by 20 analysts: 11 Analysts recommend Rocket Pharmaceuticals, Inc. to buy, 7 to hold and 2 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Rocket Pharmaceuticals, Inc. stock has an average upside potential 2027 of 298.44% register free of charge . Most analysts recommend the Rocket Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.01	-0.15
	26.37%	92.54%
P/E		negative
EV/Sales		17.73

16 Analysts have issued a Rocket Pharmaceuticals, Inc. forecast for earnings per share. The average Rocket Pharmaceuticals, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.01	26.37%
2026	$-0.15 92.54% unlock
2027	$-1.39 826.67% unlock
2028	$-1.12 19.42% unlock
2029	$-0.31 72.32% unlock
2030	$0.08 125.81% unlock
2031	$0.64 700.00% unlock
2032	$1.46 128.13% unlock
2033	$0.87 40.41% unlock

Current	-17.27	1,123.46%
2026	-17.03 1.37% unlock
2027	-1.86 89.08% unlock
2028	-2.31 24.19% unlock
2029	-8.39 263.20% unlock
2030	32.76 490.46% unlock
2031	4.06 87.61% unlock
2032	1.77 56.40% unlock
2033	2.99 68.93% unlock

Rocket Pharmaceuticals, Inc....

Current Rocket Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Needham	Locked ➜ Locked	Locked	Sep 16 2026
Wedbush	Locked ➜ Locked	Locked	Sep 16 2026
Chardan Capital	Locked ➜ Locked	Locked	Sep 15 2026
Chardan Capital	Locked ➜ Locked	Locked	Sep 01 2026
Wedbush	Locked ➜ Locked	Locked	Aug 11 2026
Chardan Capital	Locked ➜ Locked	Locked	May 11 2026
B of A Securities	Locked ➜ Locked	Locked	Mar 30 2026

Analyst Rating	Date
Locked Needham: Locked ➜ Locked	Sep 16 2026
Locked Wedbush: Locked ➜ Locked	Sep 16 2026
Locked Chardan Capital: Locked ➜ Locked	Sep 15 2026
Locked Chardan Capital: Locked ➜ Locked	Sep 01 2026
Locked Wedbush: Locked ➜ Locked	Aug 11 2026
Locked Chardan Capital: Locked ➜ Locked	May 11 2026
Locked B of A Securities: Locked ➜ Locked	Mar 30 2026

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 81.89%

Rheinmetall 70.55%

Tencent Holdings Ltd. 61.28%

Adyen 56.67%

Uber Technologies 51.26%

BYD 50.30%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now